IDiyas

For the Inventor, By the Inventor

Cincinnati, OH, United States of America

Richard C Dage

USPTO Granted Patents = 52

 

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 204(Granted Patents)

Forward Citations (Not Self Cited) = 166(Oct 12, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal47 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
silverMedal4 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 236 
 
Hoechst Marion Roussel
 patents

Years Active: 1982-2000

Loading Chart...
Loading Chart...
52 patents (USPTO):Explore Patents
1. 6013645 - Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic (2000-01-11),
2. 5624921 - Hypotriglyceridemic aminoacetylmercapto derivatives (1997-04-29),
3. 5602122 - Method for lowering total serum cholesterol and treating (1997-02-11),
4. 5541201 - Antiarrhythmic piperidin-1-yl-2,2-dialkylpropanone arylsulfonamide (1996-07-30),
5. 5500433 - Method of treating drug abuse (1996-03-19),
6. 5484783 - Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic (1996-01-16),
7. 5478846 - 1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac (1995-12-26),
8. 5428045 - 5-acyl-2-(1H)-pyridinoes (1995-06-27),
9. 5292752 - Antithrombotic compounds (1994-03-08),
10. 5286866 - Piperidinyl compounds (1994-02-15),
11. 5212315 - Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones (1993-05-18),
12. 5212314 - Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones (1993-05-18),
13. 5166211 - Method of using 1,4-disubstituted piperidinyl compounds in the treatment (1992-11-24),
14. 5118696 - 5-Acyl-2-(1H)-pyridinones useful for treating cardiac failure (1992-06-02),
15. 5093341 - N-aralkyl piperidine derivatives useful as antithrombolytic agents (1992-03-03),

Title: Richard C Dage: A Pioneer in Inventions and Innovations

Introduction:

Richard C Dage, a notable inventor based in Cincinnati, OH, has garnered recognition for his passion for innovation and relentless drive to create solutions that shape the future. With an impressive portfolio of 52 patents, Dage has significantly impacted various industries with his groundbreaking inventions.

Latest Patents:

Among his latest patents is the groundbreaking work on "Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic - Hypotriglyceridemic aminoacetylmercapto derivatives." This invention focuses on utilizing specific aminoacetylmercapto derivatives to treat patients grappling with hypertriglyceridemia, atherosclerosis, and hypercholesterolemia.

Career Highlights:

Richard C Dage has made significant contributions to the field of inventions through his tenure at renowned companies such as Merrell Dow Pharmaceuticals and Merrell Pharmaceuticals, Inc. His innovative spirit and dedication to creating impactful solutions have set him apart as a true trailblazer in the world of inventions.

Collaborations:

Throughout his career, Dage has collaborated with esteemed professionals in the industry, including Richard A Schnettler and Winton D Jones. These collaborations have not only enriched his work but have also led to the development of innovative solutions that address key challenges in various sectors.

Conclusion:

In conclusion, Richard C Dage's exceptional passion for innovation, coupled with his relentless pursuit of creating solutions for the future, positions him as a true pioneer in the realm of inventions. His work continues to leave a lasting impact on diverse industries, showcasing his unwavering commitment to driving progress through groundbreaking inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…